Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Corey

Showing results (541-550 of 551) with videos related to

Pageof 56
Sort By:
Viruses|October 28, 2023
Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 TrialYing Huang, Nima S Hejazi, Bryan Blette, et al.
Ebiomedicine|August 24, 2025
Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320Avi Kenny, Janine van Duijn, One Dintwe, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Induction of multiple HIV-1 neutralizing B Cell Precursors in HumansChen-Hao Yeh, Stephen R Walsh, Ruth Parsons, et al.
Ebiomedicine|September 5, 2024
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control studyAvi Kenny, Janine van Duijn, One Dintwe, et al.
The New England Journal of Medicine|March 24, 2021
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in AdultsGlenda E Gray, Linda-Gail Bekker, Fatima Laher, et al.
Nature Communications|November 12, 2024
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trialLindsay N Carpp, Ollivier Hyrien, Youyi Fong, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical TrialYouyi Fong, Adrian B McDermott, David Benkeser, et al.
Nature Microbiology|November 10, 2022
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trialYouyi Fong, Adrian B McDermott, David Benkeser, et al.
Iscience|November 10, 2025
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trialAlex Luedtke, Youyi Fong, Lars van der Laan, et al.
Eclinicalmedicine|February 4, 2025
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) studyNigel Garrett, Asa Tapley, Aaron Hudson, et al.
Pageof 56

Showing results (541-550 of 551) with videos related to

Sort By:
Pageof 56
Viruses|October 28, 2023
Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 TrialYing Huang, Nima S Hejazi, Bryan Blette, et al.
Ebiomedicine|August 24, 2025
Corrigendum to 'Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study'. EBioMedicine 2024;108: 105320Avi Kenny, Janine van Duijn, One Dintwe, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Induction of multiple HIV-1 neutralizing B Cell Precursors in HumansChen-Hao Yeh, Stephen R Walsh, Ruth Parsons, et al.
Ebiomedicine|September 5, 2024
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control studyAvi Kenny, Janine van Duijn, One Dintwe, et al.
The New England Journal of Medicine|March 24, 2021
Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in AdultsGlenda E Gray, Linda-Gail Bekker, Fatima Laher, et al.
Nature Communications|November 12, 2024
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trialLindsay N Carpp, Ollivier Hyrien, Youyi Fong, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical TrialYouyi Fong, Adrian B McDermott, David Benkeser, et al.
Nature Microbiology|November 10, 2022
Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trialYouyi Fong, Adrian B McDermott, David Benkeser, et al.
Iscience|November 10, 2025
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trialAlex Luedtke, Youyi Fong, Lars van der Laan, et al.
Eclinicalmedicine|February 4, 2025
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) studyNigel Garrett, Asa Tapley, Aaron Hudson, et al.
Pageof 56